“A NOVEL FORMULATION DESIGN FOR EXTENDED RELEASE TABLET OF ETODOLAC FOR THE TREATMENT OF RHEUMATOID ARTHRITIS” (2022) Journal of Pharmaceutical Negative Results, pp. 972–979. doi:10.47750/pnr.2022.13.S01.116.